# CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia

> **NCT01013441** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 20 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** Infusion of CD3/CD28 stimulated T cells

## Key facts

- **NCT ID:** NCT01013441
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013441, "CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01013441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*